15 Nov 2022 , 11:37 AM
Net profit of ANG Lifesciences India declined 79.52% to Rs 2.63 crore in the quarter ended September 2022 as against Rs 12.84 crore during the previous quarter ended September 2021. Sales declined 33.13% to Rs 59.82 crore in the quarter ended September 2022 as against Rs 89.46 crore during the previous quarter ended September 2021.
| Particulars | Quarter Ended | ||
| ? | Sep. 2022 | Sep. 2021 | % Var. |
| Sales | 59.82 | 89.46 | -33 |
| OPM % | 16.13 | 22.19 | – |
| PBDT | 6.50 | 18.31 | -65 |
| PBT | 4.39 | 17.11 | -74 |
| NP | 2.63 | 12.84 | -80 |
Powered by Capital Market – Live News
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
